Role of Tissue Factor in Cancer

作者: Raj S. Kasthuri , Mark B. Taubman , Nigel Mackman

DOI: 10.1200/JCO.2009.22.6324

关键词:

摘要: Tissue factor (TF) is a transmembrane glycoprotein that localizes the coagulation serine protease VII/VIIa (FVII/VIIa) to cell surface. The primary function of TF activate clotting cascade. TF:FVIIa complex also activates cells by cleavage G-protein coupled receptor called protease-activated 2 (PAR2). expressed tumor and contributes variety pathologic processes, such as thrombosis, metastasis, growth, angiogenesis. For instance, release TF-positive procoagulant microparticles into circulation these may trigger venous thromboembolism in patients with cancer. on circulating leads coating fibrin traps them within microvasculature facilitates hematogenous metastasis. In addition, TF:FVIIa-dependent activation PAR2 increases growth via an undefined mechanism. One possibility PAR2-dependent signaling expression proangiogenic proteins. Other studies have reported endothelial vasculature express this enhance These results suggest inhibition should reduce several pathways increase This would represent novel approach anticancer therapy. Initial using inhibitors mouse models produced encouraging results. Nevertheless, additional are needed determine if strategy can be successfully translated treatment cancer patients.

参考文章(63)
J. H. Morrissey, T. A. Drake, Procoagulant Response of the Endothelium and Monocytes Springer, Berlin, Heidelberg. pp. 564- 574 ,(1993) , 10.1007/978-3-642-76736-4_41
John A. Heit, Cancer and venous thromboembolism: scope of the problem. Cancer Control. ,vol. 12, pp. 5- 10 ,(2005) , 10.1177/1073274805012003S02
Mamoru Shoji, Bohdan Kudryk, Josephine Contrino, Dirck L. Dillehay, Wayne W. Hancock, Wayne W. Hancock, Indrani Danave, Indrani Danave, Donald L. Kreutzer, Rosalie M. Baine, Josiah N. Wilcox, Thomas S. Edgington, James H. Morrissey, Katherine A. Casper, Katherine A. Casper, Keisuke Abe, Keisuke Abe, Frederick R. Rickles, Cornelia Micko, Cornelia Micko, Stuart Gordon, Eileen Matthews, Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. American Journal of Pathology. ,vol. 152, pp. 399- 411 ,(1998)
Joseph S. Palumbo, Keith W. Kombrinck, Angela F. Drew, Timothy S. Grimes, John H. Kiser, Jay L. Degen, Thomas H. Bugge, Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood. ,vol. 96, pp. 3302- 3309 ,(2000) , 10.1182/BLOOD.V96.10.3302
Nigel Mackman, Regulation of the tissue factor gene. The FASEB Journal. ,vol. 9, pp. 883- 889 ,(1995) , 10.1096/FASEBJ.9.10.7615158
F. B. Taylor, T. A. Drake, J. Cheng, Al Chang, Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. American Journal of Pathology. ,vol. 142, pp. 1458- 1470 ,(1993)
I Del Conde, LD Bharwani, DJ Dietzen, U Pendurthi, P Thiagarajan, José A López, None, Microvesicle-associated tissue factor and Trousseau's syndrome. Journal of Thrombosis and Haemostasis. ,vol. 5, pp. 70- 74 ,(2007) , 10.1111/J.1538-7836.2006.02301.X
Shaun R. Coughlin, Thrombin signalling and protease-activated receptors Nature. ,vol. 407, pp. 258- 264 ,(2000) , 10.1038/35025229
A M Dvorak, V S Harvey, D Anderson, W DeWolf, A M Bitzer, H F Dvorak, G L Davis, R Bach, A C Carvalho, L Van DeWater, Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Cancer Research. ,vol. 43, pp. 4434- 4442 ,(1983)
Joseph S. Palumbo, Kathryn E. Talmage, Jessica V. Massari, Christine M. La Jeunesse, Matthew J. Flick, Keith W. Kombrinck, Markéta Jirousková, Jay L. Degen, Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell–mediated elimination of tumor cells Blood. ,vol. 105, pp. 178- 185 ,(2005) , 10.1182/BLOOD-2004-06-2272